Nexilico, Inc.
Danville, CA Doing business as Nexilico Inc.
- UEI
- Z2H3SNX8WJ36
- CAGE
- 7YGZ9
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 98 Amberfield Ln, Danville, CA 94506, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation - project summary / abstract the… | National Institute of Environmental Health Sciences | $275,765 | |
| Sbir phase II: an omics-based computational drug design and discovery platform for next generation microbiome… | National Science Foundation | $1,623,498 | |
| Computational prediction of GUT microbiome-mediated drug metabolism - project summary / abstract notwithstanding… | National Center for Advancing Translational Sciences | $1,085,000 | |
| Sbir phase i: an omics-based computational platform for the personalization of GUT microbiome therapeutics | Division of Industrial Innovation | $224,995 | |
| A predictive computational platform for GUT microbiome precision medicine | National Institute of General Medical Sciences | $224,929 |
About Nexilico, Inc.
Nexilico, Inc. is a for-profit organization that provides research and development services to the federal government through grant awards focused on microbiome and computational biology research. According to its website, Nexilico develops novel probiotics and microbiome therapeutics leveraging computational techniques.
Through past prime federal grants, Nexilico has provided research on novel probiotics to mitigate toxicity of environmental chemicals, with a focus on arsenicals, awarded by the National Institutes of Health. It has also conducted research on an omics-based computational platform to accelerate development of microbiome therapeutics for diseases like diabetes, awarded by the National Science Foundation. Additional services include prediction of gut microbiome-mediated drug metabolism to improve treatment effectiveness and reduce adverse reactions, provided through a grant from National Institutes of Health. Nexilico has partnered with research universities on some of these awards.
Quick answers
What is Nexilico, Inc.'s UEI?
Nexilico, Inc.'s Unique Entity ID (UEI) in SAM.gov is Z2H3SNX8WJ36.
What is Nexilico, Inc.'s CAGE code?
Nexilico, Inc.'s CAGE code is 7YGZ9.
What is Nexilico, Inc.'s primary NAICS code?
Nexilico, Inc.'s primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Nexilico, Inc. located?
Nexilico, Inc.'s physical address in SAM.gov is 98 Amberfield Ln, Danville, CA 94506, USA.
Is Nexilico, Inc. registered in SAM.gov?
Yes. Nexilico, Inc.'s SAM.gov registration is active through September 21, 2027.
What is Nexilico, Inc.'s most recent federal award?
Nexilico, Inc.'s most recent federal grant award is Novel probiotics to mitigate xenobiotic toxicity through microbial biotransformation - project summary / abstract the… (R41ES034979), from National Institute of Environmental Health Sciences, on September 1, 2023.
On GovTribe
See Nexilico, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors